Search research articles
Contact Us
Filters
Showing results (241-250 of 262) with videos related to
Page
of 27
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 7, 2017
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Ingrid E Lundberg, Anna Tjärnlund, Matteo Bottai, et al.
Annals of the Rheumatic Diseases
|
October 29, 2017
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E Lundberg, Anna Tjärnlund, Matteo Bottai, et al.
RMD Open
|
November 28, 2017
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
Matteo Bottai, Anna Tjärnlund, Giola Santoni, et al.
Rheumatology International
|
October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Leonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Arthritis and Rheumatism
|
September 28, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report
Tuhina Neogi, Daniel Aletaha, Alan J Silman, et al.
The New England Journal of Medicine
|
March 30, 2026
A Phase 3 Trial of Brepocitinib in Dermatomyositis
Ruth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
Rheumatology (Oxford, England)
|
March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys
Kshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)
|
March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Leonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)
|
April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
Naveen R, Parikshit Sen, Zoltán Griger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 28, 2024
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project
Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 262) with videos related to
Sort By:
Page
of 27
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 7, 2017
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Ingrid E Lundberg, Anna Tjärnlund, Matteo Bottai, et al.
Annals of the Rheumatic Diseases
|
October 29, 2017
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E Lundberg, Anna Tjärnlund, Matteo Bottai, et al.
RMD Open
|
November 28, 2017
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
Matteo Bottai, Anna Tjärnlund, Giola Santoni, et al.
Rheumatology International
|
October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Leonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Arthritis and Rheumatism
|
September 28, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report
Tuhina Neogi, Daniel Aletaha, Alan J Silman, et al.
The New England Journal of Medicine
|
March 30, 2026
A Phase 3 Trial of Brepocitinib in Dermatomyositis
Ruth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
Rheumatology (Oxford, England)
|
March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys
Kshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)
|
March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Leonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)
|
April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
Naveen R, Parikshit Sen, Zoltán Griger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 28, 2024
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project
Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, et al.
Page
of 27